跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
尼拉帕利阿比特龙片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Niraparib Tosylate and Abiraterone Acetate Tablets
Approved
化学药品
Niraparib Tosylate and Abiraterone Acetate Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Oct 16, 2024
Approval ID
8dzNaCMYp7C
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8dzNaCMYp7C
Approval Number
国药准字HJ20240110
Generic Name
尼拉帕利阿比特龙片
Generic Name En
Niraparib Tosylate and Abiraterone Acetate Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含甲苯磺酸尼拉帕利50mg（按C₁₉H₂₀N₄O计）和醋酸阿比特龙500mg
Reg Date
2024-10-16
Expired Date
2029-10-15
Company Name
Janssen-Cilag International NV
Production Company Name
PATHEON FRANCE
Company Detail Path
/organization/janssen-cilag-international-nv
Production Company Detail Path
/organization/patheon-france
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 16, 2024
Approval ID
8dzNaCMYp7C
Type
化学药品
Back to NMPA Approvals
